Dawn of a new era for treatment of Childhood TB
Dr Amitava Acharyya, CNS Correspondent, India
TB continues to be a major infectious disease among children. Southeast Asia and Western Pacific regions are bearing more than 50% of the total childhood TB cases. India alone accounts for 27% of the global burden of paediatric TB. Nearly 5% of the new cases in India are reported among children. Early diagnosis and proper treatment plays a crucial role in not only improving cure rates but also in reducing the burden of drug sensitive as well as multi drug resistant TB (MDR-TB), the latter affecting 32,000 children globally.
TB continues to be a major infectious disease among children. Southeast Asia and Western Pacific regions are bearing more than 50% of the total childhood TB cases. India alone accounts for 27% of the global burden of paediatric TB. Nearly 5% of the new cases in India are reported among children. Early diagnosis and proper treatment plays a crucial role in not only improving cure rates but also in reducing the burden of drug sensitive as well as multi drug resistant TB (MDR-TB), the latter affecting 32,000 children globally.[Call to register] Webinar for media in lead up to World Cancer Day 2016
A new year gift: Child friendly drugs to cure paediatric TB
Dr Richa Sharma, CNS Correspondent, India
TB has been known to mankind since ancient times and has claimed many lives every year since then. Children form a vulnerable category for many infections and TB is no different in this regard. According to the World Health Organization (WHO), 1 million children became infected with TB in 2014 and 140,000 died because of it. Yet children remain largely neglected in this regard.
Half the battle won with child-friendly TB drugs
Catherine Mwauyakufa, CNS Correspondent, Zimbabwe
We
end the year 2015 with a sigh of relief for children as there has been a
milestone achievement in TB treatment for children. A new and effective
TB formulation for children has been unveiled. The world’s first
appropriate child-friendly fixed dose combination (FDC) medicine to
treat children with drug sensitive TB will soon be available in the
market. This is bound to make medication, and hence treatment of
childhood TB more manageable.
|